DexCom (NasdaqGS:DXCM) is upgrading its Stelo glucose monitoring platform with AI driven features that expand its nutrition database and deliver more personalized health insights. The new tools focus ...

Wearables in healthcare must advance to a stage where they provide actionable insights in addition to datapoints.

Wall Street expects a year-over-year increase in earnings on higher revenues when DexCom (DXCM) reports results for the ...

Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter ...

DexCom reported strong preliminary Q4 results, with topline figures above its earlier expectations. The company paired this ...

In his first solo album in almost five years, Nick Jonas referenced his health struggle in the song 'Sweet to Me' from the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Abbott (NYSE:ABT) is facing an FDA warning letter alleging quality system regulation violations related to FreeStyle Libre ...

Abbott Laboratories (NYSE:ABT) received an FDA warning letter focused on the accuracy and testing of its FreeStyle Libre ...

Southeast Asia Medical Wearable Devices Market was valued at ~USD 2,080.65 million in 2024 grow at a strong CAGR of ...

Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled ...

ETHealthworld.com brings latest abbott laboratories news, views and updates from all top sources for the Indian Health industry.